Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tarceva plus Chemotherapy in Advanced NSCLC
NCT00047736Phase 3Completed
- Sponsor
- Genentech
- Start
- Jul 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of erlotinib in non-small cell lung cancer (NSCLC), sponsored by Genentech. Started Jul 2001; status: completed.
02
Drugs
erlotinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00047736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00047736.